Reynolds syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Reynolds syndrome | |
|---|---|
| File:Autosomal dominant - en.svg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Scleroderma, Primary biliary cholangitis |
| Complications | Pulmonary hypertension, Liver cirrhosis |
| Onset | Middle age |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | Autoimmune disease |
| Diagnosis | Clinical evaluation, Antinuclear antibody test |
| Differential diagnosis | CREST syndrome, Systemic sclerosis |
| Prevention | N/A |
| Treatment | Symptomatic treatment, Immunosuppressive drugs |
| Medication | Ursodeoxycholic acid, Calcium channel blockers |
| Prognosis | Variable, depends on organ involvement |
| Frequency | Rare |
| Deaths | N/A |
Reynolds syndrome is a rare autoimmune disease characterized by the combination of primary biliary cholangitis (PBC) and systemic sclerosis (SSc). It is named after the American physician Telfer B. Reynolds, who first described the syndrome.
Presentation[edit]
Patients with Reynolds syndrome typically present with symptoms of both primary biliary cholangitis and systemic sclerosis. Common symptoms include:
- Fatigue
- Pruritus (itching)
- Jaundice
- Raynaud's phenomenon
- Sclerodactyly (thickening and tightening of the skin on the fingers)
- Telangiectasia (small dilated blood vessels near the surface of the skin)
Pathophysiology[edit]
The exact cause of Reynolds syndrome is unknown, but it is believed to involve an abnormal immune response that targets the body's own tissues. In PBC, the immune system attacks the small bile ducts in the liver, leading to progressive liver damage. In SSc, the immune system targets the connective tissue, leading to fibrosis and vascular abnormalities.
Diagnosis[edit]
Diagnosis of Reynolds syndrome is based on clinical presentation, laboratory tests, and imaging studies. Key diagnostic criteria include:
- Positive anti-mitochondrial antibodies (AMA) for PBC
- Positive anti-centromere antibodies (ACA) for SSc
- Liver biopsy showing features of PBC
- Skin biopsy showing features of SSc
Treatment[edit]
There is no cure for Reynolds syndrome, and treatment is primarily aimed at managing symptoms and slowing disease progression. Treatment options include:
- Ursodeoxycholic acid for PBC
- Immunosuppressive drugs for SSc
- Calcium channel blockers for Raynaud's phenomenon
- Physical therapy for skin and joint involvement
Prognosis[edit]
The prognosis for patients with Reynolds syndrome varies depending on the severity of liver and skin involvement. Early diagnosis and treatment can help manage symptoms and improve quality of life.
See also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian